Bench
to
Clinic

Dr. Wang graduated from Beijing Medical University, received his postdoctorate research fellowship training in immunology from Washington University School of Medicine in St. Louis, and his resident physician training from University of Minnesota School of Medicine. He holds medical licenses in California and Colorado with clinical expertise in anesthesiology, pain medicine and critical care. Dr. Wang is a visiting professor in China National Engineering Research Center for Protein Drugs. He is also the founders of several biotech startups, including Beijing ATGC Gene Tech Corp, one of the leading clinical diagnostic companies providing services in personalized medicine; and Immunoah Therapeutics, a clinical stage pharmaceutical company in cancer immunotherapy. 

Dr. Zhou received his M.S. in Analytical Chemistry and his PhD in Polymer Chemistry from Wuhan University. He had his postdoctoral training in Biochemistry from Cambridge University. He has more than 25 years of experience in bioconjugate chemistry, polymer chemistry, glycobiology, and the development of molecular diagnostics and drug delivery systems based on nanomaterials. He has served as Principle Investigator for 18 of federal funded research projects. Dr. Zhou is the inventor for natural glycan microarrays and glyconanoparticles.

• University of Colorado School of Medicine
• Beijing Medical University
• China National Engineering Research Center for Protein Drugs
• GS Medical Biotechnology Development Corp

Golden Probe Dx is a novel clinical diagnostic system for point of care testing (POCT) featuring minimal sample prep, multiplex, ultra high sensitivity and specificity, and low cost. It can be applied in early cancer screening, TDM, and neural diseases.

Nearly 99% small molecules and 100% large molecules can not cross blood brain barrier. We are developing proprietary bionanomaterials and device to facilitate safe and efficient nasal administration for CNS delivery.  

Exosomes, with diameter 30-100 nm,  play a key role in processes such as coagulation,  intercellular signalling, and waste management. Recently, there is a growing interest in the clinical applications of exosomes in both diagnosis and therapy. We are developing a novel method to quickly isolate and purify exosomes for research and clinical applications.